Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruth Van Daele

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Expert Opinion on Drug Metabolism & Toxicology|June 2, 2020
Posaconazole in prophylaxis and treatment of invasive fungal infections: a pharmacokinetic, pharmacodynamic and clinical evaluationRuth Van Daele, Isabel Spriet, Johan Maertens
Antimicrobial Agents and Chemotherapy|March 30, 2021
Fluconazole Underexposure in Critically Ill Patients: a Matter of Using the Right Targets?Ruth Van Daele, Yves Debaveye, Katrien Lagrou, et al.
Frontiers in Pharmacology|May 28, 2020
Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs?Wannee Kantasiripitak, Ruth Van Daele, Matthias Gijsen, et al.
Mycoses|September 23, 2021
Interaction between flucloxacillin and azoles: Is isavuconazole next?Ruth Van Daele, Joost Wauters, Christophe Vandenbriele, et al.
Antibiotics (Basel, Switzerland)|June 2, 2021
Pharmacokinetic/Pharmacodynamic Target Attainment Based on Measured versus Predicted Unbound Ceftriaxone Concentrations in Critically Ill Patients with Pneumonia: An Observational Cohort StudyMatthias Gijsen, Erwin Dreesen, Ruth Van Daele, et al.
Medical Mycology|July 12, 2019
Antifungal drugs: What brings the future?Ruth Van Daele, Isabel Spriet, Joost Wauters, et al.
Infection|December 6, 2024
Anidulafungin exposure and population pharmacokinetics in critically ill patients with invasive candidiasisOmar Elkayal, Yannick Hoffert, Beatrijs Mertens, et al.
The Journal of Antimicrobial Chemotherapy|September 20, 2022
Comment on: Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenationBeatrijs Mertens, Ruth Van Daele, Yves Debaveye, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2020
Ultra-performance liquid chromatography for quantification of amphotericin B plasma concentrations after use of liposomal amphotericin BRuth Van Daele, Yvo de Beer, Sander Croes, et al.
Therapeutic Drug Monitoring|February 9, 2021
A Population Pharmacokinetic Modeling and Simulation Study of Posaconazole Oral Suspension in Immunocompromised Pediatric Patients: A Short CommunicationOmar Elkayal, Isabel Spriet, Anne Uyttebroeck, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Expert Opinion on Drug Metabolism & Toxicology|June 2, 2020
Posaconazole in prophylaxis and treatment of invasive fungal infections: a pharmacokinetic, pharmacodynamic and clinical evaluationRuth Van Daele, Isabel Spriet, Johan Maertens
Antimicrobial Agents and Chemotherapy|March 30, 2021
Fluconazole Underexposure in Critically Ill Patients: a Matter of Using the Right Targets?Ruth Van Daele, Yves Debaveye, Katrien Lagrou, et al.
Frontiers in Pharmacology|May 28, 2020
Software Tools for Model-Informed Precision Dosing: How Well Do They Satisfy the Needs?Wannee Kantasiripitak, Ruth Van Daele, Matthias Gijsen, et al.
Mycoses|September 23, 2021
Interaction between flucloxacillin and azoles: Is isavuconazole next?Ruth Van Daele, Joost Wauters, Christophe Vandenbriele, et al.
Antibiotics (Basel, Switzerland)|June 2, 2021
Pharmacokinetic/Pharmacodynamic Target Attainment Based on Measured versus Predicted Unbound Ceftriaxone Concentrations in Critically Ill Patients with Pneumonia: An Observational Cohort StudyMatthias Gijsen, Erwin Dreesen, Ruth Van Daele, et al.
Medical Mycology|July 12, 2019
Antifungal drugs: What brings the future?Ruth Van Daele, Isabel Spriet, Joost Wauters, et al.
Infection|December 6, 2024
Anidulafungin exposure and population pharmacokinetics in critically ill patients with invasive candidiasisOmar Elkayal, Yannick Hoffert, Beatrijs Mertens, et al.
The Journal of Antimicrobial Chemotherapy|September 20, 2022
Comment on: Isavuconazole plasma concentrations in critically ill patients during extracorporeal membrane oxygenationBeatrijs Mertens, Ruth Van Daele, Yves Debaveye, et al.
The Journal of Antimicrobial Chemotherapy|December 22, 2020
Ultra-performance liquid chromatography for quantification of amphotericin B plasma concentrations after use of liposomal amphotericin BRuth Van Daele, Yvo de Beer, Sander Croes, et al.
Therapeutic Drug Monitoring|February 9, 2021
A Population Pharmacokinetic Modeling and Simulation Study of Posaconazole Oral Suspension in Immunocompromised Pediatric Patients: A Short CommunicationOmar Elkayal, Isabel Spriet, Anne Uyttebroeck, et al.
Pageof 3